Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab for the treatment of cervical cancer.
Marret G, Borcoman E, Le Tourneau C. Marret G, et al. Among authors: borcoman e. Expert Opin Biol Ther. 2019 Sep;19(9):871-877. doi: 10.1080/14712598.2019.1646721. Epub 2019 Jul 23. Expert Opin Biol Ther. 2019. PMID: 31322926 Review.
Patterns of Response and Progression to Immunotherapy.
Borcoman E, Nandikolla A, Long G, Goel S, Le Tourneau C. Borcoman E, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:169-178. doi: 10.1200/EDBK_200643. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231380 Free article. Review.
Novel patterns of response under immunotherapy.
Borcoman E, Kanjanapan Y, Champiat S, Kato S, Servois V, Kurzrock R, Goel S, Bedard P, Le Tourneau C. Borcoman E, et al. Ann Oncol. 2019 Mar 1;30(3):385-396. doi: 10.1093/annonc/mdz003. Ann Oncol. 2019. PMID: 30657859 Free article.
Molecular profiling in precision medicine oncology.
Le Tourneau C, Borcoman E, Kamal M. Le Tourneau C, et al. Among authors: borcoman e. Nat Med. 2019 May;25(5):711-712. doi: 10.1038/s41591-019-0442-2. Nat Med. 2019. PMID: 31036881 No abstract available.
Hyperprogression under Immunotherapy.
Frelaut M, Le Tourneau C, Borcoman E. Frelaut M, et al. Among authors: borcoman e. Int J Mol Sci. 2019 May 30;20(11):2674. doi: 10.3390/ijms20112674. Int J Mol Sci. 2019. PMID: 31151303 Free PMC article. Review.
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.
Moreira A, Masliah-Planchon J, Callens C, Vacher S, Lecerf C, Frelaut M, Borcoman E, Torossian N, Ricci F, Hescot S, Sablin MP, Tresca P, Loirat D, Melaabi S, Trabelsi-Grati O, Pierron G, Gentien D, Bernard V, Vincent Salomon A, Servant N, Bieche I, Le Tourneau C, Kamal M. Moreira A, et al. Among authors: borcoman e. Eur J Cancer. 2019 Nov;121:202-209. doi: 10.1016/j.ejca.2019.09.001. Epub 2019 Oct 5. Eur J Cancer. 2019. PMID: 31593830
51 results